Pinsent Masons advises Bryan, Garnier & Co on Heidelberg Pharma AG’s capital increase
28 Jun 2021 | 02:23 pm |
Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.
The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.
The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.
Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.
The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).
Commenting on the transaction, Dr Susanne Lenz said:
"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons launches online tool to spot future home-working related litigation for financial services firms
Multinational law firm Pinsent Masons has launched a new working-from home audit tool to help financial services organisations understand the hidden litigation and regulatory risks associated with staff increasingly working from home on a more permanent basis.
Pinsent Masons advises Seraphine Group PLC on its £150m main market IPO
Multinational law firm Pinsent Masons is advising Seraphine Group plc, an international digitally-led maternity and nursing wear, on its IPO and premium listing on the main market of the London Stock Exchange.
Pinsent Masons agrees MOU with Nepal International ADR Center
Multinational law firm Pinsent Masons has today signed a memorandum of understanding (MOU) with Nepal International ADR Center (NIAC), commencing an important collaborative relationship seeking to enhance NIAC’s international arbitration capabilities.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises on first digital asset-based fund listing on Nasdaq Dubai
Multinational law firm Pinsent Masons has advised leading digital asset management company 3iQ Corp (3iQ) on its listing of The Bitcoin Fund on Nasdaq Dubai.
Pinsent Masons collaborates with LifeArc on expert paper to support drug repurposing
Multinational law firm Pinsent Masons has collaborated with medical research charity LifeArc, on a new report offering expert advice, insights and practical tips to charities, researchers and funders hoping to repurpose drugs for other – often rare and fatal – conditions.
Pinsent Masons advises UCL on £300m sustainability bond
Multinational law firm Pinsent Masons has advised University College London (UCL) on its debut issue of £300m 1.625% sustainability bonds due 2061 - the first publicly listed sustainability bonds in the higher education sector.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: pressoffice[email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]